Qiming U.S. Ventures Management, LLC

Q3 2025 13F Holdings

  • Location
    bellevue, WA
  • Num holdings

    4

  • Value ($000)

    $55,637

  • Date Filed
    11/10/2025
  • Form type
    13F-HR
  • CIK
    0001909617
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

TOURMALINE BIO INC

COM
89157D105
$35.48M
64 %

741,691

K
KRRO

KORRO BIO INC

COM
500946108
$17.63M
32 %

368,085

J
JSPR

JASPER THERAPEUTICS INC

COM NEW
471871202
$2.21M
4 %

928,964

---

KEZAR LIFE SCIENCES INC

COM NEW
49372L209
$323.20K
1 %

82,871

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 4 of 4